Teleradiology provider USARad, a subsidiary of Nanox, is extending its collaboration with AI developer AZmed to further integrate AZmed’s Rayvolve x-ray AI suite into its reading workflows.
The suite covers eight applications on musculoskeletal and chest x-rays that are cleared by the U.S. Food and Drug Administration (FDA). It includes the following:
AZtrauma for detecting fractures, dislocations, and joint effusions in patients ages 2 and older.
AZchest for detecting and localizing pneumothorax, pleural effusion, consolidation, and increased cardiothoracic ratio on frontal chest radiographs.
Rayvolve LN for detecting pulmonary nodules.
USARad has used AZtrauma since 2023 and added AZchest this year, the company said. The AI will now be delivered through Nanox Marketplace, which automatically routes studies and transmits DICOM data between AZmed’s software and facilities on OnePacs, USARad’s cloud PACS, according to the vendor. As a result, radiologists see AI results within the system they already read in, Nanox said.
